PROLENSA: payments to doctors
Payments that named PROLENSA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $777K
- Providers
- 6,409
- Transactions
- 20,054
- Average per transaction
- $39
The per-transaction average — $39 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 6,409 providers the average total is $121, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLC | $583,830 | 75.2% |
| Bausch & Lomb Americas Inc. | $192,939 | 24.8% |